GO TO
- How to Join
- Renew Membership
- News
- Events
- Publications
- Presentations
- Sponsors
- Corporate Members
- Links
SPONSORS
Board of Directors
TBI is governed by a Board of Directors that represent Ontario’s pharmaceutical and biotechnology industry. These elected directors provide guidance and set policy for TBI, facilitating The Biotechnology Intiative’s strong voice in advocacy and economic development in Ontario.
TBI Board of Directors, effective May 2008
|
Adi Treasurywala
ArrowCan Partners
|
|
Allan Odette
GlaxoSmithKline Canada
|
|
Anita Nador
McCarthy Tetrault
|
|
Anthony Giovinazzo
Cervelo Pharmaceuticals Ltd.
|
|
Bonnie Kuehl
Scientific Insights Consulting Group Inc.
|
|
Dale Patterson
Canadian Medical Discoveries Fund
|
|
Darlene Homonko
Golden Horseshoe Venture Forum
|
|
David Young
Arius Research
|
|
Denis Ferkany
ICAV
|
|
Geoff Collett
AstraZeneca Canada Inc.
|
|
Grant Tipler
RBC Royal Bank
|
|
Janet Lambert
Ontario Long Term Care Association
|
|
Jason Locklin
Sanofi Pasteur Limited
|
|
Jeffrey Graham
Borden Ladner Gervais LLP
|
|
John Kelly
MaRS Landing
|
|
Karen Atkinson
Ernst & Young LLP
|
|
Matt Buist
City of Toronto, Office of Economic Dev.
|
|
Tim McTiernan
The Innovations Group University of Toronto
|
